Journal of Nanoparticle Research

, Volume 9, Issue 6, pp 1217–1220

A response to ‘Nanotechnology and the need for risk governance’, O. Renn & M.C. Roco, 2006. J. Nanoparticle Research 8(2): 153–191

Authors

  • W. E. Bijker
    • Faculty of Arts and CultureUniversity Maastricht
  • I. D. de Beaufort
    • Department of Medical EthicsErasmus Medical Center Rotterdam
  • A. van den Berg
    • MESA+Institute, BIOS the Lab-on-a-chip GroupUniversity of Twente
  • P. J. A. Borm
    • Center of Expertise in Life SciencesHogeschool Zuyd
    • Institut für Umweltmedizinische ForschungHeinrich-Heine University
  • W. J. G. Oyen
    • Department of Nuclear MedicineRadboud University Nijmegen Medical Centre
  • G. T. Robillard
    • BioMaDe Technology
    • Health Council of the Netherlands
Brief Communication

DOI: 10.1007/s11051-007-9261-3

Cite this article as:
Bijker, W.E., de Beaufort, I.D., van den Berg, A. et al. J Nanopart Res (2007) 9: 1217. doi:10.1007/s11051-007-9261-3

Copyright information

© Springer Science+Business Media B.V. 2007